Chronic Obstructive Pulmonary Disease Market Analysis, Segmented Overview and Outlook

Hexa Reports
Market Research Reports and Insightful Company Profiles
Chronic Obstructive Pulmonary Disease (COPD) Market Size,
Share, Treatment, Symptoms, Analysis, Segmented Overview
and Outlook, Pipeline Review, H1 2016
Global Markets Direct's, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016',
provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Chronic
Obstructive Pulmonary Disease (COPD), complete with analysis by stage of development, drug target,
mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers
the descriptive pharmacological action of the therapeutics, its complete research and development
history and latest news and press releases. Additionally, the report provides an overview of key players
involved in therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and features
dormant and discontinued projects.
Browse Detail Report With TOC @ http://www.hexareports.com/report/chronic-obstructivepulmonary-disease-copd-pipeline-review-h1-2016/details
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and information sourced from Global
Markets Direct's proprietary databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic
review following a stringent set of processes to ensure that all the profiles are updated with the latest
set of information. Additionally, various dynamic tracking processes ensure that the most recent
developments are captured on a real time basis.
Hexa Reports
Market Research Reports and Insightful Company Profiles
The report helps in identifying and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective counter strategies to gain
competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance
of data.
Scope
- The report provides a snapshot of the global therapeutic landscape of Chronic Obstructive Pulmonary
Disease (COPD)
- The report reviews pipeline therapeutics for Chronic Obstructive Pulmonary Disease (COPD) by
companies and universities/research institutes based on information derived from company and
industry-specific sources
- The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product
description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental
activities
- The report reviews key players involved Chronic Obstructive Pulmonary Disease (COPD) therapeutics
and enlists all their major and minor projects
- The report assesses Chronic Obstructive Pulmonary Disease (COPD) therapeutics based on drug target,
mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Chronic Obstructive Pulmonary
Disease (COPD)
Reasons To Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D
strategies
- Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Chronic
Obstructive Pulmonary Disease (COPD)
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline
therapeutics
- Devise corrective measures for pipeline projects by understanding Chronic Obstructive Pulmonary
Disease (COPD) pipeline depth and focus of Indication therapeutics
Hexa Reports
Market Research Reports and Insightful Company Profiles
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with
the most attractive projects to enhance and expand business potential and Scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors
that drove them from pipeline
Request A Sample copy of This Report @ http://www.hexareports.com/sample/119041
Table of Contents
Table of Content 2
Introduction 7
Chronic Obstructive Pulmonary Disease (COPD) Overview 8
Therapeutics Development 9
Chronic Obstructive Pulmonary Disease (COPD) - Therapeutics under Development by Companies 11
Chronic Obstructive Pulmonary Disease (COPD) - Therapeutics under Investigation by
Universities/Institutes 21
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Products Glance 22
Chronic Obstructive Pulmonary Disease (COPD) - Products under Development by Companies 26
Chronic Obstructive Pulmonary Disease (COPD) - Products under Investigation by Universities/Institutes
40
Chronic Obstructive Pulmonary Disease (COPD) - Companies Involved in Therapeutics Development 41
Chronic Obstructive Pulmonary Disease (COPD) - Therapeutics Assessment 150
Drug Profiles 170
Chronic Obstructive Pulmonary Disease (COPD) - Recent Pipeline Updates 449
Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects 546
Chronic Obstructive Pulmonary Disease (COPD) - Discontinued Products 568
Chronic Obstructive Pulmonary Disease (COPD) - Product Development Milestones 574
Appendix 583
Browse Full Report @ http://www.hexareports.com/report/chronic-obstructive-pulmonary-diseasecopd-pipeline-review-h1-2016/details
About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom
research and consulting services to a host of key industries across the globe. We offer comprehensive
business intelligence in the form of industry reports which help our clients obtain clarity about their
business environment and enable them to undertake strategic growth initiatives.
Hexa Reports
Market Research Reports and Insightful Company Profiles
Contact Information:
Ryan Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: [email protected]
Our Website: http://www.hexareports.com/
Visit Our Blogs: http://hexareports.blogspot.in

Global Markets Direct's, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016', provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) pipeline landscape.